Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)
NCT00042029
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
324
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
MK0869, aprepitant
DRUG:
Comparator: placebo
Sponsor
Merck Sharp & Dohme LLC